Cargando…
Activation of the p53-MDM4 regulatory axis defines the anti-tumour response to PRMT5 inhibition through its role in regulating cellular splicing
Evasion of the potent tumour suppressor activity of p53 is one of the hurdles that must be overcome for cancer cells to escape normal regulation of cellular proliferation and survival. In addition to frequent loss of function mutations, p53 wild-type activity can also be suppressed post-translationa...
Autores principales: | Gerhart, Sarah V., Kellner, Wendy A., Thompson, Christine, Pappalardi, Melissa B., Zhang, Xi-Ping, Montes de Oca, Rocio, Penebre, Elayne, Duncan, Kenneth, Boriack-Sjodin, Ann, Le, BaoChau, Majer, Christina, McCabe, Michael T., Carpenter, Chris, Johnson, Neil, Kruger, Ryan G., Barbash, Olena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018746/ https://www.ncbi.nlm.nih.gov/pubmed/29946150 http://dx.doi.org/10.1038/s41598-018-28002-y |
Ejemplares similares
-
Regulation of constitutive and alternative splicing by PRMT5 reveals a role for Mdm4 pre-mRNA in sensing defects in the spliceosomal machinery
por: Bezzi, Marco, et al.
Publicado: (2013) -
PRMT5 inhibition disrupts splicing and stemness in glioblastoma
por: Sachamitr, Patty, et al.
Publicado: (2021) -
Targeting MDM4 Splicing in Cancers
por: Bardot, Boris, et al.
Publicado: (2017) -
Regulation of PRMT5–MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma
por: AbuHammad, Shatha, et al.
Publicado: (2019) -
A Chemical Acetylation-Based Mass Spectrometry Platform for Histone Methylation Profiling
por: Zappacosta, Francesca, et al.
Publicado: (2021)